Trial intelligence / Profile preview

Lysozyme enteric-coated tablets added to conventional therapy for psoriasis

ChiCTR2000029848Phase 4Not yet recruiting

Sponsor
Affiliated Hospital of Chongqing Three Gorges Medical College
Start
Mar 2020
Modality
Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4 trial of lysozyme in psoriasis (2 arms), sponsored by Affiliated Hospital of Chongqing Three Gorges Medical College. Primary endpoints: Efficacy evaluation, PGA improvement and 5 more. Planned start Mar 2020; status: not yet recruiting.

02

Drugs

lysozyme
03

Conditions

psoriasis

Beyond the preview

Go deeper on ChiCTR2000029848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000029848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call